Your legal partner

Jesper Lykkesfeldt

Founder, Attorney-at-Law

Jesper Lykkesfeldt is the founder of LYKKESFELDT and brings over 20 years of professional experience in the life science industry.

Prior to founding LYKKESFELDT, Jesper served as Head of Legal, Global R&D and Corporate Strategy, at the international biotech company Genmab where he oversaw all legal aspects of the company’s global R&D, business development and licensing, partnerships, M&A, and dispute resolution globally.

He led two international teams totaling 17 legal professionals, was a member of the global leadership and DK site leadership teams and served as a standing member of Genmab’s Business Development Committee – the decision-making body for all strategic deals.

Jesper played a central role in drafting and negotiating some of Genmab’s largest partnership agreements, with total deal values reaching several billion US dollars. He also led legal support for Genmab’s USD 1.8 billion acquisition of ProfoundBio in 2024 and the subsequent integration process.

Jesper is an attorney-at-law (“advokat”), admitted to the Danish bar. He holds a Master of Laws (LL.M) from the University of Copenhagen. Earlier in his career, Jesper worked as external counsel at leading law firms in Copenhagen, advising prominent international pharma and biotech clients and gaining deep experience in IP litigation, including in the US, China and various jurisdictions in Europe.

In addition to his professional work, Jesper serves as chairman of the board of directors for Holms Mindelegat, a foundation that supports research and other activities related to cancer and infirm children.